Antisickling Agents
- Name
- Antisickling Agents
- Accession Number
- DBCAT001227
- Description
Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.
- Drugs
Drug Drug Description Hydroxyurea An antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip). Efaproxiral Not Available Methyl isocyanate Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia. Cetiedil Not Annotated - Drugs & Drug Targets